Stay updated on Dexmedetomidine for Bipolar Agitation Clinical Trial
Sign up to get notified when there's something new on the Dexmedetomidine for Bipolar Agitation Clinical Trial page.

Latest updates to the Dexmedetomidine for Bipolar Agitation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 in the page footer, indicating a new site release. This change represents a metadata update to the page rather than content or functionality changes.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history shows a new site revision (v3.6.3) added, replacing the previous v3.6.2, indicating a minor platform update. This reflects internal maintenance or UI/bug fix improvements rather than changes to the study information.SummaryDifference0.1%

- Check42 days agoChange DetectedThe revision history now lists Revision: v3.6.2 and removes Revision: v3.6.0, reflecting a new administrative version entry for the study record.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry (v3.6.0) was added to the record history, and the recruitment status indicates no further participant enrollment; the prior revision (v3.5.5) was removed from the history.SummaryDifference0.4%

- Check63 days agoChange DetectedThe version history now includes new items and labels such as 'More Information' and 'Study Status' for the latest update, and the revision tag has advanced to v3.5.5 on 2026-06-04; an earlier revision entry (v3.5.4) from 2023-09-11 was removed.SummaryDifference0.6%

- Check85 days agoChange DetectedNew revision (v3.5.4) appears in the Record History, replacing v3.5.3. This reflects an update to the page's revision history rather than changes to trial data or content.SummaryDifference0.1%

Stay in the know with updates to Dexmedetomidine for Bipolar Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexmedetomidine for Bipolar Agitation Clinical Trial page.